Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC10069 NSC 23766 trihydrochloride Inhibitor of Rac1
  3. GC17886 Stattic

    STAT3 Inhibitor V

    Stattic是第一个非肽类小分子STAT3抑制剂,能有效抑制STAT3的激活和核转位。
  4. GC11015 PD168393 An irreversible EGFR kinase inhibitor
  5. GC10467 Irbesartan

    厄贝沙坦; SR-47436; BMS-186295

    An AT1 receptor antagonist

  6. GC12094 PHT-427

    4-十二烷基-N-1,3,4-噻二唑-2-基苯磺酰胺

    An inhibitor of Akt and PDPK1
  7. GC15658 R406(free base) A potent and selective Syk inhibitor
  8. GC16380 AZD8055

    CCG-168

    AZD8055是一种新型的ATP竞争性mTOR抑制剂,IC50 为0.8 nmol/L,Ki为1.3 nmol/L。
  9. GC15870 AT7519

    4-[(2,6-二氯苄基)氨基]-N-4-哌啶1H-吡唑-3-羧胺,AT7519M

    A Cdk inhibitor
  10. GC16835 LY2228820

    5-[2-(叔丁基)-4-(4-氟苯基)-1H-咪唑-5-基]-3-(2,2-二甲基丙基)-3H-咪唑并[4,5-B]吡啶-2-胺甲磺酸盐,LY2228820 dimesylate

    A potent inhibitor of p38α MAP kinase
  11. GC15047 PHA-793887

    3-甲基-N-[1,4,5,6-四氢-6,6-二甲基-5-[(1-甲基-4-哌啶基)甲酰基]吡咯并[3,4-C]吡唑-3-基]丁酰胺

    A CDK inhibitor
  12. GC11892 AEE788 (NVP-AEE788)

    6-[4-[(4-乙基-1-哌嗪)甲基]苯基]-N-[(1R)-1-苯基乙基]-7H-吡咯并[2,3-D]嘧啶-4-胺,NVP-AEE 788

    An inhibitor of EGFR and VEGFR tyrosine kinases
  13. GC13394 Ispinesib (SB-715992)

    伊斯平斯; SB-715992

    An Eg5 inhibitor
  14. GC14144 Fludarabine

    氟达拉滨; F-ara-A; NSC 118218

    Fludarabine是一种抑制DNA合成的嘌呤类似物。
  15. GC16868 Sulfasalazine

    柳氮磺吡啶; NSC 667219

    A prodrug form of 5-aminosalicylic acid
  16. GC16732 TSU-68 (SU6668,Orantinib)

    SU6668; TSU-68

    An inhibitor of select receptor tyrosine kinases
  17. GC15166 Perindopril Erbumine

    培哚普利叔丁胺; Perindopril tert-butylamine salt; S-9490 erbumine

    An orally active ACE inhibitor
  18. GC17955 Vatalanib (PTK787) 2HCl

    瓦他拉尼,PTK787 dihydrochloride; CGP-797870 dihydrochloride; ZK-222584 dihydrochloride

    A potent and selective VEGF receptor inhibitor
  19. GC11202 Epothilone A

    埃博霉素A,Epo A

    An antimicrotubule agent
  20. GC17094 Acitretin

    阿维A; Ro 10-1670

    A retinoid
  21. GC13598 MGCD-265

    N-(3-氟-4-(2-(1-甲基-1H-咪唑-4-基)噻吩并[3,2-B]吡啶-7-氧基)苯基氨基硫代甲酰基)-2-苯乙酰胺

    A c-Met and VEGFR2 inhibitor
  22. GC16818 BX-912 A potent inhibitor of PDK1
  23. GC14957 OSI-930

    噻尔非尼

    A dual inhibitor of Kit and VEGFR2
  24. GC17240 Epothilone B (EPO906, Patupilone)

    埃博霉素B; EPO 906; Patupilone

    Microtubule stabilizing agent
  25. GC10662 WYE-354

    4-[6-[4-[(甲氧羰基)氨基]苯基]-4-(4-吗啉基)-1H-吡唑并[3,4-D]嘧啶-1-基]-1-哌啶羧酸甲酯

    Potent inhibitor of mTOR in both mTORC1 and mTORC2
  26. GC13091 CP-724714

    2-甲氧基-N-[(2E)-3-[4-[[3-甲基-4-[(6-甲基-3-吡啶基)氧基]苯基]氨基]-6-喹唑啉基]-2-丙烯-1-基]乙酰胺

    A selective HER2/ErbB2 tyrosine kinase inhibitor
  27. GC15779 Cabozantinib (XL184, BMS-907351)

    卡博替尼; XL184; BMS-907351

    Cabozantinib (XL184,BMS-907351) 是一种新型 MET 和 VEGFR2 抑制剂,可同时抑制转移、血管生成和肿瘤生长。
  28. GC10591 Nelarabine

    奈拉滨; 506U78; GW 506U78; Nelzarabine

    A nucleoside analog used in the treatment of leukemia
  29. GC13044 17-DMAG (Alvespimycin) HCl

    阿螺旋霉素盐酸盐; 17-DMAG hydrochloride; KOS-1022; BMS 826476

    Water-soluble inhibitor of Hsp90
  30. GC15665 Quercetin dihydrate

    二水槲皮素

    槲皮素二水合物是一种天然类黄酮,是重组 SIRT1 的刺激剂和 PI3K 抑制剂,对 PI3K γ、PI3K δ 和 PI3K β 的 IC50 分别为 2.4 μM、3.0 μM 和 5.4 μM。
  31. GC13968 SB202190 (FHPI)

    4-(4-氟苯基)-2-(4-羟基苯基)-5-(4-吡啶基)-1H-咪唑

    SB 202190是一种选择性p38 MAP激酶抑制剂,对p38α和p38β2的IC50分别为50 nM和100 nM。
  32. GC17958 Linifanib (ABT-869)

    利尼伐尼,ABT-869; AL-39324

    A dual VEGFR and PDGFR family kinase inhibitor
  33. GC12709 XL147

    XL147 analogue

    An analog of XL147
  34. GC11396 SNS-032 (BMS-387032)

    BMS-387032

    A Cdk2, Cdk7, and Cdk9 inhibitor
  35. GC10686 Epirubicin HCl

    盐酸表柔比星; 4'-Epidoxorubicin hydrochloride

    An anthracycline antitumor antibiotic

  36. GC10893 Dutasteride

    度他雄胺; GG 745; GI 198745

    An inhibitor of steroid 5α-reductase
  37. GC11499 Enzastaurin (LY317615)

    恩扎妥林; LY317615

    An inhibitor of PKC and Akt signaling
  38. GC13697 AG-1024

    Tyrphostin AG 1024

    AG-1024是一种可逆的,竞争性和选择性的胰岛素样生长因子-1受体(IGF-1R)抑制剂,IC50值为7µM。AG-1024能够抑制胰岛素受体(IR)的磷酸化,IC50值为57µM。
  39. GC14485 Dacarbazine

    达卡巴嗪; Imidazole Carboxamide

    A DNA alkylating prodrug
  40. GC10509 Cladribine

    克拉屈滨; 2-Chloro-2′-deoxyadenosine; CldAdo; 2CdA

    A nucleoside analog and prodrug form of 2-CdATP
  41. GC13410 Masitinib (AB1010)

    马赛替尼; AB1010

    An inhibitor of c-Kit
  42. GC15617 Etoposide

    依托泊苷; VP-16; VP-16-213

    Etoposide(VP-16)是一种非特异性拓扑异构酶II(Topoisomerase II)抑制剂,IC50值为59.2 μM。
  43. GC13636 BIBR 1532

    2-[[(2E)-3-(2-萘基)-1-氧代-2-丁烯基]氨基]苯甲酸

    A potent telomerase inhibitor
  44. GC12989 PD184352 (CI-1040)

    2-[(2-氯-4-碘苯基)氨基]-N-(环丙基甲氧基)-3,4-二氟-苯甲酰胺,PD 184352

    A potent MEK inhibitor
  45. GC11089 SU11274

    N-(3-氯苯基)-N-甲基-3-[[3,5-二甲基-4-[(4-甲基哌嗪-1-基)羰基-1H-吡咯-2-基]亚甲基]-2-氧代-2,3-二氢-1H-吲哚-5-磺酰胺,PKI-SU11274

    A potent, selective inhibitor of c-Met
  46. GC10610 Adapalene

    阿达帕林; CD271

    An RARβ and RARγ agonist
  47. GC11733 PHA-665752

    (2R)-1-[[5-[(Z)-[5-[[(2,6-二氯苯基)甲基]磺酰]-1,2-二氢-2-氧代-3H-吲哚-3-亚基]甲基]-2,4-二甲基-1H-吡咯-3-基]羰基]-2-(1-吡咯烷甲基)吡咯烷

    A selective c-Met inhibitor
  48. GC14102 Genistein

    染料木素; NPI 031L

    染料木黄酮是一种异黄酮,属于类黄酮化合物,存在于多种植物中。
  49. GC11165 PI-103 A potent, cell-permeable PI3-kinase inhibitor
  50. GC15219 Clofarabine

    氯法拉滨

    A ribonucleotide reductase and DNA polymerase-α inhibitor
  51. GC10744 Bendamustine HCl

    盐酸苯达莫司汀; SDX-105

    A DNA alkylating agent

Items 2301 to 2350 of 2733 total

per page

Set Descending Direction